Rhode Island Senate Bill S2254

Rhode Island 2026 Regular Session

• Introduced: 1/23/26
• Refer: 1/23/26

Caption

Requires every individual or group health insurance contract effective on or after January 1, 2027, to provide coverage to the insured and the insured's spouse and dependents for all FDA-approved contraceptive drugs, devices and other products.

Impact

The bill's implementation is expected to significantly enhance access to contraceptive methods without additional cost-sharing for patients. Insurers cannot impose deductibles, copayments, or coinsurance on the specified contraceptive services, fostering a more supportive framework for reproductive health choices. This change will likely improve public health outcomes by facilitating easier access to contraceptives and fostering informed reproductive health decisions among residents.

Summary

S2254 mandates that all individual and group health insurance contracts in the state provide coverage for FDA-approved contraceptive drugs, devices, and related services starting January 1, 2027. This applies to all health insurance contracts that include prescription coverage and aims to ensure that individuals do not face prohibitive costs when accessing necessary contraceptive care. Additionally, it requires coverage for voluntary sterilization procedures, consultations, and follow-up services associated with contraception.

Contention

Notably, S2254 includes provisions allowing religious employers to opt out of covering certain contraceptive methods that conflict with their religious beliefs. This aspect of the bill has the potential to ignite debates concerning the balance between individual health rights and religious liberties. Opponents of the exemption argue that it could limit access to necessary health care for those who fall under such employers' insurance plans, thereby imposing a restriction on reproductive health choices for those employees.

Implementation

The bill also outlines mechanisms for monitoring compliance through the insurance commissioner, including random reviews and annual reports to the legislative assembly. Stakeholder engagement is emphasized, ensuring that various community groups, including those representing minorities and low-income populations, have a voice in the regulatory process pertaining to the implementation of these provisions.